0 Patents (Medical) associated with Hubei Zenith Airbeck Pharmaceutical Co. Ltd.

Upon completion of the vend in of assets from the Hubei Pharmaceutical Factory (operated by Chinese government owned Hubei Zenith Airbeck Pharmaceutical Co. Ltd. since 1968) into the Hubei Pharmaceutical Company Ltd. joint venture, the Company will issue 19,000,000 common shares to Red Dot Capital Inc. to complete the transaction.

OVERVIEW Hubei Zenith Airbeck Pharmaceutical Co. Ltd. ("Airbeck"), formerly Hubei Pharmaceutical Factory, a Chinese state owned enterprise, was one of China's original four largest pharmaceutical production facilities. First commissioned in 1968, it produced high quality pharmaceuticals in high volume throughout the late 1960's, 70's and 80's ...

VANCOUVER BRITISH CO A1 999999999 SECURITIES AND EXCHANGE COMMISSION FORM 10KSB Annual and transition reports of small business issuers [Section 13 or 15(d), not S-B Item 405] Filing Date: | Period of Report: SEC Accession No. 0001012182 (HTML Version on secdatabase) FILER HUBEI …

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: JANUARY 31, 2004 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES …

Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Link ID: 63049: Title: Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Url: : Description: …

Hubei Zenith Airbeck Pharmaceutical. Manufacturing · China · <25 Employees . It is a modern pharmacy enterprise that integrates medicine, production and sales. We have advanced equipment, complete detecting instruments, erfect QC system. We are approved by all government structures .

Hubei Zenith Airbeck Pharmaceutical Company manufactures pharmaceutical products. In addition it exports its products to markets such as America, South-East Asia, …

0001013946 sample contracts and agreements. Interest Transferring Agreement Party A: Hubei Zenith Airbeck Pharmaceutical Co., Ltd. Party B: Hubei Pharmaceutical Group Ltd. U.S.A. Party C: Xiangfan Sanli Company of Hubei Zenith Group

Hubei Zenith Airbeck Pharmaceutical. Contact us. Company is located in China. Hubei Zenith Airbeck Pharmaceutical TOP partners: Use filtering, Hubei Zenith

10KSB 1 doc1.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: JANUARY 31, 2004 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE …

u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended april 30th, 2004 commission file no. 0-25553 hubei pharmaceutical group ltd.

Hubei Zenith Airbeck Pharmaceutical Company manufactures pharmaceutical products. In addition it exports its products to markets such as America, South-East Asia, Europe, and …

NEW YORK, July 10, 2003 (PRIMEZONE) -- Hubei Pharmaceutical Group, Ltd. (OTCBB:HBEI), Hubei Zenith Airbeck Pharmaceutical Co. ...

Tianjin Xingyun Biotechnology Development Co., Ltd. Link ID: 93179: Title: Tianjin Xingyun Biotechnology Development Co., Ltd. Url: : Description: …

For all the operation behaviors of Party B that are irrelevant to Hubei United Pharmaceutical Co., Ltd. and Hubei Zenith Airbeck Pharmaceutical Co., Ltd., the …

10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended july 31st, 2003 commission file no. 0 …

10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended october 31st, 2003 commission file no. …

OTHER EVENTS PRIVATE PLACEMENT - On July 31st, 2003 Hubei Pharmaceutical Group, Ltd. (the "Company") closed on a private placement of 693,333 units at a price of $0.30 each consisting of one share of common stock and one warrant to purchase an additional share of common stock at a price of $0.80 if exercised on or before July 31st, …

I N D E X PAGE ----- PART I FINANCIAL INFORMATION ITEM 1 FINANCIAL STATEMENTS Consolidated Balance Sheets 3 Consolidated Statement of Operations 4 Statements of Retained Earnings 5 Statement of Cash Flows 6 Statement of Stockholders' Equity 7 - 8 NOTES TO THE CONSOLIDATE FINANCIAL STATEMENTS 1 Organization …

On April 2, 2003 the Corporation announced that that the name change and share consolidation (reverse split) had been approved by the OTC Bulletin Board(R). The Hubei Pharmaceutical Group Ltd. common shares commenced trading on the OTC Bulletin Board on a post-consolidation basis on Thursday, April 3, 2003 under the new symbol HBEI.

EX-1 3 doc2.txt FURTHER RESOLVED that the President of the Corporation be given the authority to take the necessary actions to put the abovementioned resolutions into effect

Management believe that the transaction is very much in the company's favor although the overall valuation remains fixed at 30,000,000 RMB as Airbeck's contribution to the capitalization of the joint venture. For production purposes, the licenses remain registered with the SFDA for the exclusive use of Hubei Pharmaceutical Company.

Hubei Pharmaceutical Company. The net effect of the transaction is to record fixed assets in place of intangible assets on the balance sheet; to eliminate the recurrent lease payment …

NEW YORK, July 10, 2003 (PRIMEZONE) -- Hubei Pharmaceutical Group, Ltd. (OTCBB:HBEI), Hubei Zenith Airbeck Pharmaceutical Co. Ltd. (Airbeck) and Hubei Pharmaceutical Co. Ltd. (HBJV) are pleased to ...

OVERVIEW Hubei Zenith Airbeck Pharmaceutical Co. Ltd. ("Airbeck"), formerly Hubei Pharmaceutical Factory, a Chinese state owned enterprise, was one of China's original …

Accounting and financial statements for Hubei Zenith Airbeck Pharmaceutical Co. Ltd. (China) Market feasibility report for Changchun Judelong Steel Tower Group Co., Ltd. (China) Market analysis and report for Prudential Plc. (Britain) ... Auckland Translations Ltd (New Zealand) - "I am impressed with the tables and the pictures in your ...

HBJV was incorporated as a private Chinese joint venture corporation in the city of Xiangfan in Hubei province, People's Republic of China ("China") on January 24, 2003 by Red Dot and Hubei Zenith Airbeck Pharmaceutical Co. Ltd. ("Airbeck").

Hubei Zenith Airbeck Pharmaceutical Company manufactures pharmaceutical products. In addition it exports its products to markets such as America, South-East Asia, Europe, and Japan. Hubei Zenith was formerly known as Hubei Pharmaceutical Factory. The company was founded in 1968 and is based in Xiangfan, China. digitGaps report on Hubei Zenith …

united states securities and exchange commission washington, dc 20549 form 10-ksb [x] annual report under section 13 or 15(d) of the securities exchange act of

10qsb 1 doc1.txt u. s. securities and exchange commission washington, d.c. 20549 form 10-qsb [x] quarterly report under section 13 or 15(d) of the securities exchange act of 1934 for the quarter ended april 30th, 2003 commission file …